Katherine M. Szigety

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Nicole R. Infarinato, Jin H. Park, Kateryna Krytska et al. · Cancer Discovery · 2015 · 180 citations · Full text

HDAC3 ensures stepwise epidermal stratification via NCoR/SMRT-reliant mechanisms independent of its histone deacetylase activity

Katherine M. Szigety, Fang Liu, Chase Yuan et al. · Genes & Development · 2020 · 32 citations · Full text

Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription

Bryson W. Katona, Rebecca A. Glynn, Kayla E. Paulosky et al. · Cancer Research · 2019 · 29 citations · Full text

Islet-specific Prmt5 excision leads to reduced insulin expression and glucose intolerance in mice

Jian Ma, Xin He, Yan Cao et al. · Journal of Endocrinology · 2019 · 15 citations · Full text

Clinical Effectiveness of Telemedicine-Based Pediatric Genetics Care

Katherine M. Szigety, T. Blaine Crowley, Kimberly B. Gaiser et al. · PEDIATRICS · 2022 · 12 citations · Full text